Abstract Title:

Serum antibodies from epileptic patients react, at high prevalence, with simian virus 40 mimotopes.

Abstract Source:

Eur J Neurol. 2015 May ;22(5):789-95, e51-2. Epub 2015 Jan 18. PMID: 25598431

Abstract Author(s):

R Faggioli, E Mazzoni, C Borgna-Pignatti, A Corallini, G Turlà, A P Taronna, E Fiumana, F Martini, M Tognon

Article Affiliation:

R Faggioli

Abstract:

BACKGROUND AND PURPOSE: It has been demonstrated that inflammation may contribute to epileptogenesis and cause neuronal injury in epilepsy. In this study, the prevalence of antibodies to simian virus 40 (SV40), a kidney and neurotropic polyomavirus, was investigated in serum samples from 88 epileptic children/adolescents/young adults.

METHODS: Serum antibodies reacting to specific SV40 peptides were analysed by indirect enzyme-linked immunosorbent assay. Synthetic peptides corresponding to the epitopes of viral capsid proteins 1-3 were used as SV40 antigens.

RESULTS: A significantly higher prevalence of antibodies against SV40 was detected in sera from epileptic patients compared to controls (41% vs. 19%). Specifically, the highest significant difference was revealed in the cohort of patients from 1.1 to 10 years old (54% vs. 21%), with a peak in the sub-cohort of 3.1-6 years old (65% vs. 18%).

CONCLUSION: Our immunological data suggest a strong association between epilepsy and the SV40 infection.

Study Type : Human Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.